Advanced search
Publication Cover
Modern Rheumatology Volume 29, 2019 - Issue 6
Journal homepage
366
Views
10
CrossRef citations to date
0
Altmetric
Original Articles: Rheumatoid Arthritis

A randomized double-blind parallel-group phase III study to compare the efficacy and safety of NI-071 and infliximab reference product in Japanese patients with active rheumatoid arthritis refractory to methotrexate

Hiroaki MatsunoMatsuno Clinic for Rheumatic Diseases, Toyama, Japan; View further author information
&
Tsukasa MatsubaraMatsubara Mayflower Hospital, Katō, JapanCorrespondence[email protected]
View further author information
Pages 919-927 | Received 30 May 2018, Accepted 19 Sep 2018, Published online: 20 Dec 2018

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Roberto Caporali, Yannick Allanore, Rieke Alten, Bernard Combe, Patrick Durez, Florenzo Iannone, Mike T. Nurmohamed, Sang Joon Lee, Taek Sang Kwon, Jean Soo Choi, Gahee Park & Dae Hyun Yoo. (2021) Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis. Expert Review of Clinical Immunology 17:1, pages 85-100.
Read now
Christopher J. Edwards, Jana Hercogová, Helene Albrand & Aurelian Amiot. (2019) Switching to biosimilars: current perspectives in immune-mediated inflammatory diseases. Expert Opinion on Biological Therapy 19:10, pages 1001-1014.
Read now

Articles from other publishers (8)

Bruna de Oliveira Ascef, Matheus Oliveira Almeida, Ana Cristina de Medeiros-Ribeiro, Danieli Castro de Oliveira Andrade, Haliton Alves de Oliveira Junior & Patrícia Coelho de Soárez. (2023) Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis. Scientific Reports 13:1.
Crossref
Bruna de Oliveira Ascef, Matheus Oliveira Almeida, Ana Cristina de Medeiros-Ribeiro, Danieli Castro Oliveira de Andrade, Haliton Alves de Oliveira Junior & Patrícia Coelho de Soárez. (2023) Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis. JAMA Network Open 6:5, pages e2315872.
Crossref
Young Ho Lee & Gwan Gyu Song. (2021) Comparative efficacy and safety of tumor necrosis factor inhibitors and their biosimilars in patients with rheumatoid arthritis having an insufficient response to methotrexateVergleich der Wirksamkeit und Sicherheit von Tumornekrosefaktor-Inhibitoren und ihren Biosimilars bei Patienten mit rheumatoider Arthritis mit ungenügendem Ansprechen auf Methotrexat. Zeitschrift für Rheumatologie 82:3, pages 248-255.
Crossref
Young Ho Lee & Gwan Gyu Song. (2021) Comparative efficacy and safety of infliximab and its biosimilars in patients with rheumatoid arthritis presenting an insufficient response to methotrexateVergleich der Wirksamkeit und Sicherheit von Infliximab und seinen Biosimilars bei Patienten mit rheumatoider Arthritis mit ungenügendem Ansprechen auf Methotrexat. Zeitschrift für Rheumatologie 82:2, pages 114-122.
Crossref
Masanori A. Murayama, Jun Shimizu, Chie Miyabe, Kazuo Yudo & Yoshishige Miyabe. (2023) Chemokines and chemokine receptors as promising targets in rheumatoid arthritis. Frontiers in Immunology 14.
Crossref
Hala Najeeb, Farah Yasmin & Salim Surani. (2022) Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients. World Journal of Clinical Cases 10:14, pages 4327-4333.
Crossref
Mikiko SHIMIZU, Eisuke MIZUTANI, Tsuyoshi SHIGA & Masayuki HASHIGUCHI. (2022) Comparison of Clinical Equivalence of Infliximab and its Biosimilar Combinations with Methotrexate in the Treatment of Rheumatoid Arthritis. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 53:2, pages 15-24.
Crossref
Lea Lopez, Romain Griffier, Thomas Barnetche, Edouard Lhomme, Marie Kostine, Marie-Elise Truchetet, Thierry Schaeverbeke & Christophe Richez. (2022) The response to TNF blockers depending on their comparator in rheumatoid arthritis clinical trials: the lessebo effect, a meta-analysis. Rheumatology 61:2, pages 531-541.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.